Status: Available
Doxecitine and Doxribtimine-Expanded Access
This Expanded Access Record for doxecitine and doxribtimine includes the following managed access programs and status: * TK0113: Available * TK0115: No longer Available
Trial details
Biological sex: AllType: Expanded AccessSponsor: UCB BIOSCIENCES, Inc.Updated: Jun 5, 2026
Eligibility criteria
Pediatric and adult patients with a diagnosis of TK2d based on confirmed reporta... [+9]
Confirmed diagnosis of other genetic or polygenic disease likely to confound cli... [+20]